The knockdown of c-myc expression by RNAi inhibits cell proliferation in human colon cancer HT-29 cells in vitro and in vivo

Cellular and Molecular Biology Letters

Volumn 14, Issue 2, 2009, Pages 305-318

  Zhang, Xiao ^a   Ge, Yin Lin ^a   Tian, Run Hua ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

c myc; Cell proliferation; HT 29; siRNA

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; DNA; LIPOFECTAMINE; MESSENGER RNA; MYC PROTEIN; SMALL INTERFERING RNA; MYC PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HT29; COLON CANCER; COLORIMETRY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; ONCOGENE C MYB; ONCOGENE C MYC; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSIENT TRANSFECTION; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; COLON TUMOR; GENE SILENCING; GENETICS; XENOGRAFT;

MUS MUSCULUS;

ANIMALS; CELL PROLIFERATION; COLONIC NEOPLASMS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HT29 CELLS; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-MYC; RNA INTERFERENCE; TRANSPLANTATION, HETEROLOGOUS;

EID: 63449141723     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-009-0001-9     Document Type: Article

References (24)

1. Ahmed, F.E. Molecular markers that predict response to colon cancer therapy. Expert Rev. Mol. Diagn. 5 (2005) 353-375.
2. Grady, W.M. and Carethers, J.M. Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis. Gastroenterology 135 (2008) 1079-1099.
3. Grandori, C., Cowley, S.M., James, L.P. and Eisenman, R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16 (2000) 653-699. (Pubitemid 32037520)
4. Bondi, J., Bukholm, G., Nesland, J.M. and Bukholm, I.R. Expression of non-membranous beta-catenin and gamma-catenin, c-Myc and cyclin D1 in relation to patient outcome in human colon adenocarcinomas. APMIS 112 (2004) 49-56. (Pubitemid 38297167)
5. Csontos, Z., Nádasi, E., Csejtey, A., Illényi, L., Kassai, M., Lukács, L., Kelemen, D., Kvarda, A. Zólyomi, A., Horváth, O.P. and Ember, I. Oncogene and tumor suppressor gene expression changes in the peripheral blood leukocytes of patients with colorectal cancer. Tumori 94 (2008) 79-82.
6. Dang, C.V. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19 (1999) 1-11.
7. Hongxing, Z., Nancai, Y., Wen, S., Guofu, H., Yanxia, W., Hanju, H., Qian, L., Wei, M., Yandong, Y. and Hao, H. Depletion of c-Myc inhibits human colon cancer colo 320 cells' growth. Cancer Biother. Radiopharm. 23 (2008) 229-237. (Pubitemid 351630187)
8. Schwab, M., Reynders, V., Loitsch, S., Shastri, Y.M., Steinhilber, D., Schröder, O. and Stein, J. PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells. Carcinogenesis 29 (2008) 1407-1414.
9. Wilkins, J.A. and Sansom, O.J. C-Myc is a critical mediator of the phenotypes of Apc loss in the intestine. Cancer Res. 68 (2008) 4963-4966.
10. Colnot, S., Niwa-Kawakita, M., Hamard, G., Godard, C., Le Plenier, S., Houbron, C., Romagnolo, B., Berrebi, D., Giovannini, M. and Perret, C. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab. Invest. 84 (2004) 1619-1630. (Pubitemid 39600569)
11. Al-Kuraya, K., Novotny, H., Bavi, P., Siraj, A.K., Uddin, S., Ezzat, A., Sanea, N.A., Al-Dayel, F., Al-Mana, H., Sheikh, S.S., Mirlacher, M., Tapia, C., Simon, R., Sauter, G., Terracciano, L. and Tornillo, L. HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer. J. Clin. Pathol. 60 (2007) 768-772.
12. Stewart, J., Evan, G., Watson, J. and Sikora, K. Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br. J. Cancer 53 (1986) 1-6. (Pubitemid 16156079)
13. Hannon, G.J. RNA interference. Nature 418 (2002) 244-251.
14. Watson, P.H., Pon, R.T. and Shiu, R.P.C. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Res. 51 (1991) 3996-4000.
15. Hong, J., Zhao, Y. and Huang, W. Blocking c-myc and stat3 by E. coli expressed and enzyme digested siRNA in mouse melanoma. Biochem. Biophys. Res. Commun. 348 (2006) 600-605. (Pubitemid 44188606)
16. Liao, D.J. and Dickson, R.B. c-Myc in breast cancer. Endocr. Relat. Cancer 7 (2000) 143-164.
17. Kruszewski, W., Kowara, R., Rzepko, R., Warezak, C., Zieliński, J., Gryglewski, G.., Kopacz, A., Jastrzebski, T. and Pawełczyk, T. K-RAS point mutation, and amplification of C-MYC and C-ERBB2 in colon adenocarcinoma. Folia Histochem. Cytobiol. 42 (2004) 173-179. (Pubitemid 39144955)
18. Nagy, B., Szendroi, A. and Romics, I. Overexpression of CD24, c-myc and Phospholipase 2A in prostate cancer tissue samples obtained by needle biopsy. Pathol. Oncol. Res. 2008.
19. Steiner, M.S., Anthony, C.T., Lu, Y. and Holt, J.T. Antisense c-myc retroviral vector suppresses established human prostate cancer. Hum. Gene Ther. 9 (1998) 747-755. (Pubitemid 28200630)
20. Bressin, C., Bourgarel-Rey, V., Carré, M., Pourroy, B., Arango, D., Braguer, D. and Barra, Y. Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine. Anticancer Drugs 17 (2006) 181-187.
21. Zhao, H.Y., Ooyama, A., Yamamoto, M., Ikeda, R., Haraguchi, M., Tabata, S., Furukawa, T., Che, X.F., Iwashita, K.I., Oka, T., Fukushima, M., Nakagawa, M., Ono, M., Kuwano, M. and Akiyama, S.I. Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells. Cancer Lett. 270 (2008) 156-163.
22. Bertrand, J.R., Pottier, M., Vekris, A., Opolon, P., Maksimenko, A. and Malvy, C. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun. 296 (2002) 1000-1004.
23. Prendergast, G.C. Mechanisms of apoptosis by c-Myc. Oncogene 1 (1999) 2967-2987.
24. Wang, Y.H., Liu, S., Zhang, G., Zhou, C.Q., Zhu, H.X., Zhou, X.B., Quan, L.P., Bai, J.F. and Xu, N.Z. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res. 7 (2005) 220-228.